chitosan has been researched along with Foot and Mouth Disease in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 6 (75.00) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
An, M; Bai, R; Hu, Y; Li, L; Li, M; Tian, Z; Yuan, W | 1 |
Amini, MA; Azimi, SM; Mokarram, AR; Taghizadeh, M; Tajdini, F | 1 |
Bhanuprakash, V; Chandra Sekar, S; Edao, BM; Ganesh, K; Hajam, IA; Kishore, S; Nanda, RK; Rajangam, M; Ramya, K | 1 |
Chang, H; Chen, H; Ding, Y; Fang, Y; Hu, W; Lin, T; Liu, X; Lv, J; Pan, L; Shao, J; Wang, Y; Zhang, J; Zhang, Y; Zhang, Z; Zhao, F; Zhou, P | 1 |
Li, D | 1 |
Bhanuprakash, V; Edao, BM; Ganesh, K; Hajam, IA; Kishore, S; Nanda, RK; Sekar, SC | 1 |
Alkan, M; Arca, HÇ; Çokçalışkan, C; Günbeyaz, M; Gürsoy, RN; Özyörük, F; Şenel, S; Uzunlu, E | 1 |
Du, X; Huang, C; Jin, H; Kang, Y; Li, J; Su, B; Wang, B; Wang, X; Yu, Y; Zhang, X; Zhao, G | 1 |
8 other study(ies) available for chitosan and Foot and Mouth Disease
Article | Year |
---|---|
Nanoparticulate chitosan-TNF-α-VLPs activate mast cells and enhance adaptive immunity induced by foot-and-mouth disease virus-like particles in mice.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Viral; Chitosan; Foot-and-Mouth Disease; Foot-and-Mouth Disease Virus; Immunity, Cellular; Mast Cells; Mice; Rodent Diseases; Tumor Necrosis Factor-alpha; Vaccines; Vaccines, Virus-Like Particle; Viral Vaccines | 2023 |
Foot and Mouth Disease virus-loaded fungal chitosan nanoparticles for intranasal administration: impact of formulation on physicochemical and immunological characteristics.
Topics: Adjuvants, Immunologic; Administration, Intranasal; Animals; Artemia; Chitosan; Drug Carriers; Foot-and-Mouth Disease; Foot-and-Mouth Disease Virus; Guinea Pigs; Male; Nanoparticles; Rhizomucor; Viral Vaccines | 2014 |
Immunological evaluation of mannosylated chitosan nanoparticles based foot and mouth disease virus DNA vaccine, pVAC FMDV VP1-OmpA in guinea pigs.
Topics: Animals; Antibodies, Viral; Cell Line; Chitosan; Cricetinae; Enzyme-Linked Immunosorbent Assay; Foot-and-Mouth Disease; Guinea Pigs; Immunity, Cellular; Mannose; Nanoparticles; Vaccines, DNA | 2014 |
Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles.
Topics: Administration, Intranasal; Animals; Antibodies, Viral; Antigens, Viral; Cattle; Cell Proliferation; Chitosan; Foot-and-Mouth Disease; Foot-and-Mouth Disease Virus; Immunity, Mucosal; Immunoglobulin G; Lactic Acid; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; T-Lymphocytes; Trehalose; Viral Vaccines | 2014 |
Chitosan can stop or postpone the death of the suckling mice challenged with foot-and-mouth disease virus.
Topics: Animals; Antiviral Agents; Chitosan; Foot-and-Mouth Disease; Foot-and-Mouth Disease Virus; Mice; Virulence; Virus Replication | 2010 |
An effective mannosylated chitosan nanoparticle DNA vaccine for FMD virus.
Topics: Animals; Antibodies, Neutralizing; Antibodies, Viral; Chitosan; Drug Carriers; Enzyme-Linked Immunosorbent Assay; Foot-and-Mouth Disease; Foot-and-Mouth Disease Virus; Guinea Pigs; Immunoglobulin G; Nanoparticles; Neutralization Tests; Vaccines, DNA | 2012 |
Chitosan-based systems for intranasal immunization against foot-and-mouth disease.
Topics: Administration, Intranasal; Animals; Chitosan; Drug Carriers; Foot-and-Mouth Disease; Foot-and-Mouth Disease Virus; Guinea Pigs; Immunoglobulin A; Immunoglobulin G; Viral Vaccines; Virion | 2014 |
Interleukin-15 enhance DNA vaccine elicited mucosal and systemic immunity against foot and mouth disease virus.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Viral; Chitosan; Female; Foot-and-Mouth Disease; Foot-and-Mouth Disease Virus; Guinea Pigs; Humans; Immunoglobulin A, Secretory; Immunoglobulin G; Interleukin-15; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Neutralization Tests; T-Lymphocytes; Vaccines, DNA; Viral Vaccines | 2008 |